Patent details

EP4051278 Title: COMBINATION OF A PD-1 ANTAGONIST, A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR AND A CBP/BETA-CATENIN INHIBITOR FOR TREATING CANCER

Basic Information

Publication number:
EP4051278
PCT Application Number:
US2020057650
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208118141
PCT Publication Number:
WO2021086909
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF A PD-1 ANTAGONIST, A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR AND A CBP/BETA-CATENIN INHIBITOR FOR TREATING CANCER
French Title of Invention:
COMBINAISON D'UN ANTAGONISTE DE PD-1, D'UN INHIBITEUR DE TYROSINE KINASE DE VEGFR/FGFR/RET ET D'UN INHIBITEUR DE CBP/BÊTA-CATÉNINE POUR TRAITER LE CANCER
German Title of Invention:
KOMBINATION AUS EINEM PD-1-ANTAGONISTEN, EINEM VEGFR/FGFR/RET-TYROSINKINASEINHIBITOR UND EINEM CBP/BETA-CATENIN-INHIBITOR ZUM BEHANDELN VON KREBS
SPC Number:

Dates

Filing date:
28/10/2020
Grant date:
17/12/2025
EP Publication Date:
07/09/2022
PCT Publication Date:
06/05/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/12/2025
EP B1 Publication Date:
17/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/10/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/12/2025
 
 

Name:
Eisai R&D Management Co., Ltd.
Address:
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088, Japan (JP)

Name:
MSD International GmbH
Address:
Weystrasse 20, 6006 Luzern, Switzerland (CH)

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Avenue, Rahway, New Jersey 07065, United States (US)

Inventor

1

Name:
KATO, Yu
Address:
Japan (JP)

2

Name:
FUNAHASHI, Yasuhiro
Address:
Japan (JP)

3

Name:
OZAWA, Yoichi
Address:
Japan (JP)

Priority

1

Priority Number:
201962927576 P
Priority Date:
29/10/2019
Priority Country:
United States (US)

2

Priority Number:
201962927334 P
Priority Date:
29/10/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/47; A61K 31/53; A61K 39/395; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202551
Publication date:
17/12/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages